Clinical Trials · NCT00347737

The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL

Name: The Effects of Therapy With Teriparatide on Vascular Compliance and Osteoprotegerin/RANKL
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

WithdrawnN/ATeriparatide

Phase: N/A
Recruitment status: Withdrawn
Sponsor: Leland Graves III, MD
Enrollment: 0
Start date: Jun 2006
Locations: 1 site, United States
Primary endpoint: The study measures changes in vascular compliance with teriparatide 1 hour, 3 months, and 6 months after initiating teriparatide. Osteoprotegerin and RANKL levels

View Teriparatide compound reference